EMP1 identified as key driver of tumor progression in resectable pancreatic cancer

Post author:admin
Post published:July 6, 2025
Post category:uncategorized

The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the associated factor EMP1 in the progression of resectable pancreatic cancer (PC).

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Researchers create mycobacteria with kill switches to improve TB vaccine safety

UK’s iiCON leads new initiative to fund innovative solutions for tackling infection transmission

Study finds elevated sodium consumption in heart disease patients

Helpful Links

Subscribe To Us